L-arginine and nitric oxide-related compounds in plasma: Comparison of normal and arginine-free diets in a 24-h crossover study

Vascular Medicine

Volumn 4, Issue 1, 1999, Pages 27-32

  Tangphao, Oranee ^a   Chalon, Stephan ^a   Coulston, Ann M ^a   Moreno Jr , Heitor ^a   Chan, Jason R ^b   Cooke, John P ^b   Hoffman, Brian B ^c   Blaschke, Terrence F ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Chemiluminescence; L arginine; Nitrate blood; Nitric oxide blood

Indexed keywords

ARGININE; NITRIC OXIDE;

ADULT; AMINO ACID BLOOD LEVEL; ANTICOAGULATION; ARTICLE; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; DIET; DIETARY INTAKE; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRECURSOR; PRIORITY JOURNAL; VASODILATATION;

EID: 0032894777     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836x9900400105     Document Type: Article

References (32)

1. Visek WJ. Arginine needs, physiological state and usual diets. A reevaluation. J Nutr 1986; 116: 36-46.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
3. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 325-33.
4. Hutchison S, Reitz M, Sudhir K et al. Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits. Hypertension 1997; 29: 1186-91.
5. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991; 83: 1057-62.
6. Tsao PS, Theilmeier G, Singer AH, Leung LLK, Cooke JP. L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 1529-33.
7. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA. Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-72.
8. Boger RH, Bode-Boger SM. Mugge A et al. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995; 117: 273-84.
9. Wang BY, Candipan RC, Arjomandi M, Hsiun PTC, Tsao PS, Cooke JP. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996; 28: 1573-79.
10. Tsao PS, McEvoy LM, Drexler H, Butcher FC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994; 89: 2176-82.
11. Clarkson P, Adams MR, Powe AJ et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996; 97: 1989-94.
12. Dubois-Rande JL, Zelinsky R, Chabrier PE, Castaigne A, Geschwind H, Adnot S. L-arginine improves endothelium-dependent relaxation of conductance and resistance coronary arteries in coronary artery disease. J Cardiovasc Pharmacol 1992; 20: S211-S13.
13. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculalion of hypercholesterolemic patients by L-arginine. Lancet 1991; 338: 1546-50.
14. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90: 1248-53.
15. Wolf A, Zalpour C, Theilmeier G et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 1997; 29: 479-85.
16. Chauhan A, More R, Mullins P, Taylor G, Petch C, Schofield P. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol 1996; 28: 1796-804.
17. Reyes AA, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am J Physiol 1994; 267: F331-F46.
18. Kharitonov A, Lubec G, Lubec B, Hjelm M, Barnes PJ. L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 1995; 88: 135-39.
19. Muller J, Toffler G, Willich S, Stone P. Circadian variation of cardiovascular disease and sympathetic activity. J Cardiovasc Pharmacol 1987; 10: S104-S109.
20. Cohen M, Rohtla K, Lavery C, Muller J, Mittleman M. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79: 1512-16.
21. Tofler GH, Brezinski D, Schafer AI et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-18.
22. Gopalakrishnan V, Burton PJ, Blaschke TF. High-performance liquid Chromatographic assay for the quantilation of L-arginine in human plasma. Anal Chem 1996; 68: 3520-23.
23. Sonoda M, Kobayashi J, Takezawa M et al. An assay method for nitric oxide-related compound in whole blood. Anal Biochem 1997; 247: 417-27.
24. Smarason A, Allman K, Young D, Redman C. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia. Br J Obstet Gynaecol 1997; 104: 538-43.
25. Castillo L, Chapman TE, Sanchez M et al. Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci USA 1993; 90: 7749-53.
26. Castillo L, Ajami A, Branch S et al. Plasma arginine kinetics in adult man: response to an arginine-free diet. Metabolism 1994; 43: 114-122.
27. Jungersten L, Edlund A, Petersson AS, Wennmalm A. Plasma nitrate as an index of nitric oxide formation in man: analysis of kinetics and confounding factors. Clin Physiol 1996; 16: 369-79.
28. Nathorst-Westfelt U, Benthin G, Lundin S, Stenqvist O, Wennmalm A. Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol 1995; 114: 1621-24.
29. Stamler JS, Jaraki O, Osborne J et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 7674-77.
30. Meah M, Harrison N, Davies A. Nitrate and nitrite in foods and the diet. Food Addit Contam 1994; 11: 519-32.
31. Beaumier L, Castillo L, Ajami AM, Young VR. Urea cycle intermediate kinetics and nitrate excretion at normal and therapeutic intakes of arginine in humans. Am J Physiol 1995; 269: E884-E896.
32. Tangphao O, Chalon S, Moreno H Jr, Hoffman BB, Blaschke TF. Pharmacokinetics of L-arginine during chronic administration to hypercholesterolemic patients. Clin Sci 1999; 96: 199-207.